Chemed (CHE) | Stock Overview & Key Data
Chemed Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $654.62 on March 11, 2024
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Financial Highlights
Profitability
Returns and Earnings
Growth
Dividend Information
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Chemed CHE | 8.07B Mid-cap | -3.72% | -15.30% | -18.51% | -12.43% | -11.75% | -14.35% | -8.31% | -4.14% |
| HCA Healthcare HCA | 90.82B Large-cap | -3.06% | 1.23% | 13.67% | 21.32% | 26.82% | 16.85% | 120.84% | 257.33% |
| Tenet Healthcare THC | 15.71B Large-cap | -2.84% | 3.73% | 44.25% | 32.39% | 37.67% | 28.80% | 211.59% | 658.17% |
| Ensign Group ENSG | 8.75B Mid-cap | -3.29% | -2.64% | 17.84% | 9.50% | 9.75% | 9.86% | 95.90% | 225.55% |
| Option Care Health OPCH | 5.29B Mid-cap | -3.44% | -2.59% | -5.92% | 27.80% | 35.90% | 5.24% | -2.12% | 112.73% |
| Amedisys AMED | 3.19B Mid-cap | 1.34% | 3.66% | 6.97% | 5.98% | 7.45% | -1.62% | -23.25% | -55.11% |
Ownership & Short Interest
Chemed Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Chemed would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
What is CHE's 52-week high and low?
In the last 52 weeks, Chemed reached a high of $623.61 (on April 3, 2025) and a low of $457.44 (on July 8, 2025).
What is the market cap and P/E ratio for CHE?
Curious about Chemed's size and valuation? Its market capitalization stands at 8.07B. When it comes to valuation, the P/E ratio (trailing twelve months) is 26.88, and the forward P/E (looking ahead) is 22.16.
Does CHE pay dividends? If so, what's the yield?
Yes, Chemed is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.18%, and the company has paid an average of $1.37 per share annually over the past 3 years.
Who are Chemed's main competitors or similar companies to consider before investing?
When looking at Chemed, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
| Company | Mkt Cap | Sector | Industry | 1Y Return | 3Y Return |
|---|---|---|---|---|---|
| HCA Healthcare HCA | 90.82B | Healthcare | Medical Care Facilities | 16.85% | 120.84% |
| Tenet Healthcare THC | 15.71B | Healthcare | Medical Care Facilities | 28.80% | 211.59% |
| Ensign Group ENSG | 8.75B | Healthcare | Medical Care Facilities | 9.86% | 95.90% |
| Option Care Health OPCH | 5.29B | Healthcare | Medical Care Facilities | 5.24% | -2.12% |
| Amedisys AMED | 3.19B | Healthcare | Medical Care Facilities | -1.62% | -23.25% |
For a more comprehensive list, please see the Peer Performance Comparison table on this page.
What are the key financial health indicators for Chemed Corporation? (e.g., ROE, Debt/Equity)
To get a sense of Chemed's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 26.11%, the Debt to Equity ratio from the most recent quarter is 12.28, and its Gross Profit Margin stands at 33.45%.
What is the recent revenue and earnings growth for CHE?
Looking at Chemed's growth, its revenue over the trailing twelve months (TTM) was $2B. Compared to the same quarter last year (YoY), quarterly revenue grew by 9.80%, and quarterly earnings saw a YoY growth of 10.40%.
How much of CHE stock is held by insiders and institutions?
Wondering who owns Chemed stock? Company insiders (like executives and directors) hold about 2.03% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 96.37%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.